Skip to Content

Pill Imprint M 14

This orange round pill with imprint M 14 on it has been identified as: Methotrexate 2.5 mg.

Details for pill imprint M 14

This medicine is known as methotrexate. It is available as a prescription only medicine and is used for acute lymphoblastic leukemia, acute lymphocytic leukemia, acute nonlymphocytic leukemia, bladder cancer, brain tumor, breast cancer, bullous pemphigoid, cervical cancer, choriocarcinoma, cogan's syndrome, colorectal cancer, dermatomyositis, ectopic pregnancy, eczema, esophageal carcinoma, gastric cancer, graft-versus-host disease, head and neck cancer, hodgkin's lymphoma, juvenile idiopathic arthritis, lymphoma, mantle cell lymphoma, meningeal leukemia, mycosis fungoides, neoplastic diseases, non-hodgkin's lymphoma, non-small cell lung cancer, osteosarcoma, ovarian cancer, pancreatic cancer, pemphigoid, pemphigus, pityriasis rubra pilaris, psoriasis, psoriatic arthritis, rheumatoid arthritis, scleroderma, small cell lung cancer, soft tissue sarcoma, solid tumors, systemic sclerosis, trophoblastic disease, uveitis.

Drug
Methotrexate
Imprint
M 14
Strength
2.5 mg
Color
Orange
Shape
Round
Size
6mm
Availability
Prescription only

Pill Classification

National Drug Code (NDC)
003780014 - Mylan Pharmaceuticals Inc.